For investors seeking momentum, WisdomTree Global ex-U.S. Hedged Dividend Fund is probably on radar now. The fund just hit a 52-week high and is up nearly 17.8% from its 52-week low price of $21.78/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
DXUS in Focus
This ETF offers global-ex U.S. exposure to dividend-paying companies in the developed and developing economies while hedge currency fluctuations of a basket of foreign currencies relative to the U.S. dollar. It has key holdings in Japan and United Kingdom accounting for 19.1% and 13.7% share, respectively. From a sector look, financials dominates the fund’s portfolio with about one-fourth share while industrials and consumer discretionary round off the top three with a double-digit exposure each. It charges 44 basis points in annual fees (see: all the World ETFs here).
Why the Move?
The global stock market has been an area to watch lately given a pickup in economic activity in many parts of the world, robust corporate earnings, and improving investor sentiment. Additionally, political gridlock in Washington and fading hopes in Trump’s pro-growth reforms act as tailwind to the international market. Further, a weak dollar has added to the strength.
More Gains Ahead?
Currently, DXUS has a Zacks ETF Rank of 3 or ‘Hold’ rating with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank, so there is definitely still some promise for those who want to ride on this surging ETF a little longer.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, WisdomTree Global ex-U.S. Hedged Dividend Fund is probably on radar now. The fund just hit a 52-week high and is up nearly 17.8% from its 52-week low price of $21.78/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
DXUS in Focus
This ETF offers global-ex U.S. exposure to dividend-paying companies in the developed and developing economies while hedge currency fluctuations of a basket of foreign currencies relative to the U.S. dollar. It has key holdings in Japan and United Kingdom accounting for 19.1% and 13.7% share, respectively. From a sector look, financials dominates the fund’s portfolio with about one-fourth share while industrials and consumer discretionary round off the top three with a double-digit exposure each. It charges 44 basis points in annual fees (see: all the World ETFs here).
Why the Move?
The global stock market has been an area to watch lately given a pickup in economic activity in many parts of the world, robust corporate earnings, and improving investor sentiment. Additionally, political gridlock in Washington and fading hopes in Trump’s pro-growth reforms act as tailwind to the international market. Further, a weak dollar has added to the strength.
More Gains Ahead?
Currently, DXUS has a Zacks ETF Rank of 3 or ‘Hold’ rating with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank, so there is definitely still some promise for those who want to ride on this surging ETF a little longer.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>